Evaluate Quality of Life in Type 2 Diabetes, Before and After Change to Insuline Glargine
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
Primary objective:
To assess quality of Life (QoL) changes and treatment satisfaction in a real life situation
in patients with Type 2 diabetes inadequately controlled on a combination of oral
antidiabetic drugs (OAD) plus Neutral Protamine Hagedrone (NHP) insulin treatment that are
switched to insulin glargine.
Secondary objective:
To determine:
change in HbA1c, comparision of the incidence of symptomatic hypoglycemia and severe
hypoglycemia before and after introduction of insulin glargine, change in weight, change in
insulin dose.